German medical technology investor SHS Gesellschaft für Beteiligungsmanagement has held a first close for its fifth fund on €90m.
Exit of UK-based software provider set to generate 40%-plus IRR; Baird advised on auction
New partner Sascha Konwalski joins Frankfurt office; US law firm to open new offices in Europe
French drug maker is the first divestment from liquidated fund Novalpina I, now managed by Berkeley Research Group
Ylva Hannestad joins GP’s client engagement around sustainability agenda